Drug Safety being Outsourced to India! What?

Quote

anonymous

Guest
Drug Safety for Biopharma compounds being outsourced to India. Will the Drug Safety measures in place be the same as the current "Help Desk" in India. Level 2 problem may be addressed internally in four months? Will this move have Wall Street feeling more secure in investing in Shire products?
 






Let me guess, this eliminates a group out of Bannockburn? Perhaps this is another example for how the company views its employees, as fully replaceable cogs in a wheel. Engagement? Company culture? Those things don't matter anymore. We are all nails and there is one hammer that rules them all.
 






  • unk   Oct 06, 2017 at 01:09: PM
It started in July. They are terrible.
 






Why are you shocked? R&D has been a joke for years under FO and Vickers. They couldn’t even find anyone outside to take over the organization when Vickers “left” so HM got the job. FO is hardly knowledgeable about medicine, and is simply listening to his consultants about cutting costs. Buying Baxalta meant no more true research here, and outsourcing PV reduces headcount and space needs. It’s a smart move if you don’t give a crap about innovation and patients.
 






I work in Drug Safety in Bannockburn. My last day is in March. I have been told severance package is great and they give one month for each year. Is it true? It is hard to believe as usually it is only 2 weeks.
 






Even as a commercial outsider looking in, it is clear from the outside that you guys just took a 10 year step back in time. All we need is the FDA on us or a patient safety issue in the media to help our already failing reputation and challenging sales deliverables!
 






anonymous said:
Why are you shocked? R&D has been a joke for years under FO and Vickers. They couldn’t even find anyone outside to take over the organization when Vickers “left” so HM got the job. FO is hardly knowledgeable about medicine, and is simply listening to his consultants about cutting costs. Buying Baxalta meant no more true research here, and outsourcing PV reduces headcount and space needs. It’s a smart move if you don’t give a crap about innovation and patients.
Click to expand...
 






Why are you shocked? R&D has been a joke for years under FO and Vickers. They couldn’t even find anyone outside to take over the organization when Vickers “left” so HM got the job. FO is hardly knowledgeable about medicine, and is simply listening to his consultants about cutting costs. Buying Baxalta meant no more true research here, and outsourcing PV reduces headcount and space needs. It’s a smart move if you don’t give a crap about innovation and patients.


Well this isn't the case. FO has many faults but he does know medicine. He was chief resident at the Karolinska one of the leading medical institutions in the world.
 












anonymous said:
Why are you shocked? R&D has been a joke for years under FO and Vickers. They couldn’t even find anyone outside to take over the organization when Vickers “left” so HM got the job. FO is hardly knowledgeable about medicine, and is simply listening to his consultants about cutting costs. Buying Baxalta meant no more true research here, and outsourcing PV reduces headcount and space needs. It’s a smart move if you don’t give a crap about innovation and patients.


Well this isn't the case. FO has many faults but he does know medicine. He was chief resident at the Karolinska one of the leading medical institutions in the world.
Click to expand...

He may or may not know medicine... He does NOT know business. He's not paid $25 million a year to know medicine. He is paid to make good decisions and for some reason he struggles bad in that department. Baxalta was not a bad decision. Getting suckered like a fool into paying $30 billion for it was. That is awful and it falls on him along with the tanking stock price
 












His official bio says he was a resident in pediatrics. Nothing more and no mention of having been boarded. Regardless, his ability as a businessman and as a science leader are evidenced by our stock price, our pipeline, his ability to attract and keep talent, and our clever acquistions.
 












Top Bottom
Back
Quote